Burden of paediatric invasive pneumococcal disease in Europe, 2005

Epidemiology and Infection

Volumn 135, Issue 4, 2007, Pages 644-656

  McIntosh, E D G ^a,b   Fritzell, B ^c   Fletcher, M A ^c  

^a Global Medical Affairs   (United Kingdom)

^b IMPERIAL COLLEGE LONDON   (United Kingdom)

^c Wyeth Vaccines Research   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; PNEUMOCOCCUS VACCINE; POLYSACCHARIDE VACCINE;

ABSTRACT REPORT; ADOLESCENT; AGE DISTRIBUTION; ARTICLE; BLOOD CULTURE; CHILD; CONTROLLED STUDY; DISEASE SURVEILLANCE; DRUG EFFICACY; EUROPEAN UNION; HUMAN; INCIDENCE; INTERNET; MAJOR CLINICAL STUDY; MEDICAL DOCUMENTATION; MEDICAL LITERATURE; MORBIDITY; MORTALITY; NORWAY; PRESCRIPTION; SEROTYPE; SPAIN; STREPTOCOCCUS INFECTION; SWEDEN; SWITZERLAND;

ADOLESCENT; CHILD; CHILD, PRESCHOOL; COST OF ILLNESS; EUROPE; FEMALE; HUMANS; INFANT; INFANT, NEWBORN; MALE; PNEUMOCOCCAL INFECTIONS; PNEUMOCOCCAL VACCINES; VACCINES, CONJUGATE;

EID: 34247498207     PISSN: 09502688     EISSN: 14694409     Source Type: Journal    
DOI: 10.1017/S0950268806007199     Document Type: Article

References (83)

1. Centers for Disease Control and Prevention (CDC). Direct and indirect effects of routine vaccination of children with 7-valent pneumococcal conjugate vaccine on incidence of invasive pneumococcal disease - United States, 1998-2003. Morbidity and Mortality Weekly Report 2006; 54: 893-897.
2. Apicella, M. Neisseria meningitidis. In: Mandell GL, Douglas RG, Bennett JE, Dolin R, Kelvin GV (eds.), Mandell, Douglas, and Bennett's Principles and Practice of Infectious Diseases, 6th edn, vol. 2. New York: Elsevier/ChurcPill Livingstone, 2005: pp. 2498-2513.
3. Dominguez A, et al., Working Group on Invasive Disease Caused by Haemophilus influenzae. Invasive disease caused by Haemophilus influenzae: The sensitivity of statutory reporting. Annals of Epidemiology 2004; 14: 31-35.
4. Leeming JP, et al., South-West Pneumococcus Study Group. Diagnosis of invasive pneumococcal infection by serotype-specific urinary antigen detection. Journal of Clinical Microbiology 2005; 43: 4972-4976.
5. McIntyre PB], et al. A population based study of the impact of corticosteroid therapy and delayed diagnosis on the outcome of childhood pneumococcal meningitis. Archives of Disease in Childhood 2005; 90: 391-639.
6. Cornaglia G, et al., on behalf of the ESCMID Study Group for Antimicrobial Resistance Surveillance (ESGARS). European recommendations for antimicrobial resistance surveillance. Clinical Microbiology and Infection 2004; 10: 349-383.
7. Rendi-Wagner P, et al. Prospective surveillance of incidence, serotypes and antimicrobial susceptibility of invasive Streptococcus pneumoniae among hospitalized children in Austria. Journal of Antimicrobial Chemotherapy 2004; 53: 826-831.
8. Institut Scientifique de Santé Publique, Section d'Epidémiologie. Surveillance by a network of microbiology laboratories, epidemiological trends 1983-2002; November 2004 - Report: D/2004/2505/20 [in French].
9. Flamaing, J, Verhaegen J, Peetermans WE. Streptococcus pneumoniae bacteraemia in Belgium: Differential characteristics in children and the elderly population and implications for vaccine use. Journal of Antimicrobial Chemotherapy 2002; 50: 43-50.
10. Verhaegen J, et al. Antibiotic susceptibility and serotype distribution of 240 Streptococcus pneumoniae causing meningitis in Belgium 1997-2000. Acta Clinica Belgica 2003; 58: 19-26.
11. Vergison A, et al. The Belgian IPD Survey: A one-year prospective survey of invasive pneumococcal disease in children under 5. 13th European Congress of Clinical Microbiology and Infectious Diseases (ECCMID), Glasgow, 10-13 May 2003, poster 1627.
12. Prymula R, Motlova J, Kriz P. Comparison of Streptococcus pneumoniae serotypes causing acute otitis media and invasive disease in young children in the Czech Republic. Indian Journal of Medical Research 2004; 119 (Suppl.): 168-170.
13. Motlova, J. Distribution of Streptococcus pneumoniae serotypes and serogroups among patients with invasive pneumococcal diseases in the Czech Republic in 1996-2003: Background data for vaccination strategy. Epidemiologie, Mikrobiologie, Imunologie 2005; 54: 3-10.
14. Nielsen SV, Henrichsen J. Incidence of invasive pneumococcal disease and distribution of capsular types of pneumococci in Denmark, 1989-94. Epidemiology and Infection 1996; 117: 411-416.
15. Kaltoft MS, Zeuthen N, Konradsen HB. Epidemiology of invasive pneumococcal infections in children aged 0-6 years in Denmark: A 19-year nationwide surveillance study. Acta Paediatrica 2000; 89 (Suppl. 435): 3-10.
16. Konradsen HBK. Invasive pneumococcal infections in Denmark from 1995 to 1999: Epidemiology, serotypes, and resistance. Clinical and Diagnostic Laboratory Immunology 2002; 9: 358-365.
17. Kaltoft MS, Madsen J, Konradsen HB. An age-adjusted comparison of the coverage by the 7-valent pneumococcal conjugate vaccine of carried and invasive isolates from Danish children aged 12 to 83 months. 4th International Symposium on Pneumococci and Pneumococcal Disease (ISPPD-4), 9-13 May 2004, Helsinki, Finland, poster PSV-29.
18. Eskola J, et al. Epidemiology of invasive pneumococcal infections in children in Finland. Journal of the American Medical Association 1992; 268: 3323-3327.
19. Klemets P, et al. Incidence and outcome of invasive Streptococcus pneumoniae infections, Finland, 1995-2002. 4th International Symposium on Pneumococci and Pneumococcal Disease (ISPPD-4), 9-13 May 2004, Helsinki, Finland, poster EPI-42.
20. Geslin P, et al. Development of resistance to betalactams and other antibiotics of pneumococci isolated from acute otitis media in France: Statement of the National Reference Center 1995-1996. Archives de Pediatrie 1998; 5: 982-987.
21. Mehl-Auget I, et al. Surveillance of meningitis caused by H. influenzae, N. meningitidis, L. monocytogenes, S. pneumoniae by the network EPIBAC 1987-1993 [in French].
22. Olivier C, et al. Pneumococcal meningitis in children: results of a nationwide investigation (1993-1995) [in French]. Weekly Epidemiological Bulletin (Bulletin Epidémiologique Hebdomadaire) 16/2000.
23. Olivier C, et al. Community-acquired bacteraemias and septicaemias in general paediatrics: Experience from two consecutive years (1998 and 1999) [in French]. Flammarion Med Aci.Journées Parisiennes de Pédiatrie, 2000.
24. Olivier C, et al. Streptococcus pneumoniae (S. Pn) Bacteraemia and Septicaemia in French Children (Paris area); Implications for Immunization Policy. Abstract 1861 presented at the 40th Interscience Conference on Antimicrobial Agents and Chemotherapy, Toronto, Canada, September 2000.
25. Grimprel E, Floret D, and Groupe de Pathologie Infectieuse Pédiatrique. Pneumococcal bacteraemia and septicaemia: multi-centre, nationwide investigation [in French]. Medecine et Maladies Infectieuses 1994; 24 (Suppl. 5): 975-981.
26. Laurichesse H, et al. Clinical characteristics and outcome of patients with invasive pneumococcal disease, Puy-de-Dome, France, 1994-1998. European Journal of Clinical Microbiology and Infectious Diseases 2001; 20: 299-308.
27. Ovetchkine P, Cohen R, Gaudelus J. Mortality due to Streptococcus pneumoniae infection in children. A 5-year retrospective study in Ile-de-France. Archives de Pediatrie 2001; 8 (Suppl. 4): 747S-751S.
28. De Benoist AC, Laurent E, Goulet V. Invasive infections of Haemophilus influenzae, Listeria monocytogenes, meningococcus, pneumococcus, group A and group B streptococcus in France in 1997. Evolution 1991-1997 [in French]. Weekly Epidemiological Bulletin (Bulletin Epidémiologique Hebdomadaire) 15/1999.
29. Decousser JW, et al. Multicentre study of the molecular epidemiology, serotypes and antimicrobial susceptibility patterns of invasive Streptococcus pneumoniae invasive isolated from children in the Ile de France area. European Journal of Clinical Microbiology and Infectious Diseases 2004; 23: 27-33.
30. Floret D. Paediatric deaths due to community-acquired bacterial infection. Survey of French paediatric intensive care units. Archives de Pediatrie 2001; 8 (Suppl. 4): 705S-711S.
31. Aujard Y, et al. Groupe de Pathologie Infectieuse Pédiatrique (GPIP) Observatoire national des méningites bactériennes de l'enfant 2001. First year of prospective surveillance network of childhood bacterial meningitis (BM). Abstract G 1462 presented at the 42nd Interscience Conference on Antimicrobial Agents and Chemotherapy, San Diego, California, 17-30. September, 2002.
32. Von Kries R, et al. Proportion of invasive pneumococcal infections in German children preventable by pneumococcal conjugate vaccines. Clinical Infectious Diseases 2000; 31: 482-487.
33. Von Kries R, et al. Prediction of the potential benefit of different pneumococcal conjugate vaccines on invasive pneumococcal disease in German children. Paediatric Infectious Disease Journal 2002; 21: 1017-1023.
34. Siedler A, et al. and the ESPED Clinic and Laboratory Study Group. Regional differences in the epidemiology of invasive pneumococcal disease in toddlers in Germany. Paediatric Infectious Disease Journal 2005; 24: 1114-1115.
35. Syriopoulou V, et al. Epidemiology of invasive childhood pneumococcal infections in Greece. Acta Paediatrica 2000; 89 (Suppl. 435): 30-34.
36. Zissis NP, et al. Serotype distribution and antimicrobial susceptibility of Streptococcus pneumoniae causing invasive infections and acute otitis media in children. European Journal of Pediatrics 2004; 163: 364-368.
37. Principi N, Marchisio P. Epidemiology of Streptococcus pneumoniae in Italian children. Acta Paediatrica (Suppl.) 2000; 89: 40-43.
38. D'Ancona F, et al., and Italian PNC-Euro Working Group. Incidence of vaccine preventable pneumococcal invasive infections and blood culture practices in Italy. Vaccine 2005; 23: 2492-2498.
39. Spanjaard L, et al. Epidemiology of meningitis and bacteraemia due to Streptococcus pneumoniae in The Netherlands. Acta Paediatrica (Suppl.) 2000; 89: 22-26.
40. Magnus T, Andersen BM. Serotypes and resistance patterns of Streptococcus pneumoniae causing systemic disease in northern Norway. European Journal of Clinical Microbiology and Infectious Diseases 1995; 14: 229-234.
41. Pedersen MK, et al. Systemic pneumococcal disease in Norway 1995-2001: Capsular serotypes and antimicrobial resistance. Epidemiology and Infection 2004; 132: 167-75.
42. Hasseltvedt V, Høiby EA. Systemic pneumococcal disease in Norway, 2001. Eurosurveillance Weekly 2002; 6 (8), 21 Feb. 2002.
43. Serrano I, Ramirez M, Melo-Cristino J, the Portuguese Surveillance Group for the Study of Respiratory Pathogens. Invasive Streptococcus pneumoniae from Portugal: Implications for vaccination and antimicrobial therapy. Clinical Microbiology and Infection 2004; 10: 652-656.
44. Paragi M, et al. Possibility of application of new pneumococcal conjugate vaccines in children in Slovenia. Vaccine 2003; 21: 4708-4714.
45. Iglesias Sanchez L, et al. Epidemiology of invasive pneumococcal disease in children in Gipuzkoa (Spain) from 1981 to 2001. Anales Españoles de Pediatría 2002; 57: 401-407.
46. Latorre, C. Characterisation of invasive pneumococcal isolates in Catalan children up to 5 years of age, 1989-2000. Clinical Microbiology and Infection 2004; 10: 177-181.
47. Fenoll A, et al. Streptococcus pneumoniae in children in Spain: 1990-1999. Acta Paediatrica (Suppl.) 2000; 89: 44-50.
48. Villo Sirerol N, Blanco et al. Streptococcus pneumoniae and Haemophilus influenzae serotype B invasive disease. A 12-year retrospective study. Anales de Pediatria 2004; 61: 150-155.
49. Perez Mendez C, Solis et al. Predictive factors for invasive pneumococcal disease: A case-control study. Anales Españoles de Pediatría 2002; 57: 310-316.
50. Perez A, et al. Pneumococcal bacteremia in children: An 8-year review in two hospitals in Barcelona. European Journal of Clinical Microbiology and Infectious Diseases 2004; 23: 677-681.
51. Díez-Domingo J, et al., The Group for the Study of Invasive Disease. Epidemiology of invasive Streptococcus pneumoniae infections in children in Spain, 1996-1998. Journal of Infection 2002; 45: 139-143.
52. Bernaola Iturbe E, et al. (Grupo de Estudio de Enfermedad Invasora Neumococica en el Pais Vasco-Navarra). Study of the incidence of invasive pneumococcal disease in neonates and children aged less than 5 years in the Basque country and Navarre (Spain). Anales Españoles de Pediatría 2002; 57: 301-309.
53. Casado Flores J, et al. (Grupo para el Estudio de la Meningitis Neumococica). Pneumococcal meningitis in Spanish children: Incidence, serotypes and antibiotic resistance. Prospective and multicentre study. Anales Españoles de Pediatría 2002; 57: 295-300.
54. Rodriguez-Creixems M, et al. Increased incidence of pneumococcal bloodstream infections. Pediatric Infectious Diseases Journal 2003; 22: 661-663.
55. Burman LA, Norrby R, Trollfors B. Invasive pneumococcal infections: Incidence, predisposing factors, and prognosis. Review of Infectious Diseases 1985; 7: 133-142.
56. Dahl MS, et al. Invasive pneumococcal infections in Southwestern Sweden: A second follow-up period of 15 years. Scandinavian Journal of Infectious Diseases 2001; 33: 667-672.
57. Eriksson M, Henriques B, Ekdahl K. Epidemiology of pneumococcal infections in Swedish children. Acta Paediatrica 2000; 89 (Suppl. 435): 35-39.
58. Hedlund J, et al. Capsular types and antibiotic susceptibility of invasive Streptococcus pneumoniae among children in Sweden. Scandinavian Journal of Infectious Diseases 2003; 35 452-458.
59. Venetz I, Schopfer K, Mühlemann K and the Swiss Pneumococcal Study Group. Paediatric invasive pneumococcal disease in Switzerland, 1985-1994. International Journal of Epidemiology 1998; 27: 1101-1104.
60. Mühlemann K, et al. Nationwide surveillance of nasopharyngeal Streptococcus pneumoniae isolates from children with respiratory infection, Switzerland, 1998-1999. Journal of Infectious Diseases 2003; 187: E8.
61. Bille J, Bannerman E. Invasive pneumococcal infections in Switzerland [in French]. Bulletin OFSP 2000; 20: 381-385.
62. Bundesamt für Gesundheit, Abteilung Epidemiologie und Infektionskrankheiten. Sektion Impfungen 'Überwachung der Infektionen durch invasive und nicht invasive Pneumokokken im Jahr 2003'. Bulletin 52, pp. 994-1000, 20 Dec. 2004.
63. Bundesamt für Gesundheit, Abteilung Epidemiologie und Infektionskrankheiten. Sektion Bakterielle und parasitäre Krankheiten 'Epidemiologische Überwachung der Infektionen durch invasive Pneumokokken im Jahr 2001'. Bulletin 31, 29 July 2002.
64. Bundesamt für Gesundheit, Abteilung Epidemiologie und Infektionskrankheiten. Sektion Bakterielle und parasitäre Krankheiten 'Invasive Pneumokokken-Infektionen in der Schweiz 1998-1999: Empfindlichkeit auf Antibiotika und Abdeckung durch 7- und 9-valente Konjugat-Impfstoffe'. Bulletin 31, 29 July 2002.
65. Ispahani P, et al. Twenty year surveillance of invasive pneumococcal disease in Nottingham: Serogroups responsible and implications for immuni-sation. Archives of Disease in Childhood 2004; 89: 757-762.
66. Kyaw MH, et al. Incidence of invasive pneumococcal disease in Scotland, 1988-99. Epidemiology and Infection 2002; 128: 139-147.
67. Shackley F, et al. Outcome of invasive pneumococcal disease: a UK based study. Oxford Pneumococcal Surveillance Group. Archives of Disease in Childhood 2000; 83: 231-233.
68. Miller E, et al. Epidemiology of invasive and other pneumococcal disease in children in England and Wales 1996-1998. Acta Paediatrica 2000; 89 (Suppl. 435): 11-16.
69. Sleeman K, et al. Invasive pneumococcal disease in England and Wales: Vaccination implications. Journal of Infectious Diseases 2001; 183: 239-246.
70. George RC, Melegaro A. Invasive pneumococcal infection in England and Wales 1999. CDR Weekly 2001; 11 (21).
71. Kyaw MH, et al. Invasive pneumococcal disease in Scotland, 1999-2001: Use of record linkage to explore associations between patients and disease in relation to future vaccination policy. Clinical Infectious Diseases 2003; 37: 1283-1291.
72. George RC, Melegaro A. Invasive pneumococcal infection, England and Wales 2000. CDR Weekly 2003; 13 (21).
73. Robinson K, et al. Epidemiology of invasive Streptococcus pneumoniae infections in the United States, 1995-1998: Opportunities for prevention in the conjugate vaccine era. Journal of the American Medical Association 2001; 285: 1729-1735.
74. Torzillo PJ, et al. Invasive pneumococcal disease in central Australia. Medical Journal of Australia 1995; 162: 182-186.
75. Noah N, Henderson B. Surveillance of bacterial meningitis in Europe 1999/2000. Communicable Disease Surveillance Centre, European Bacterial Meningitis Surveillance Project. Public Health Laboratory Service 2002.
76. Fletcher et al. Controlling invasive pneumococcal disease: is vaccination of at-risk groups sufficient? International Journal of Clinical Practice 2006; 60: 450-456.
77. Finn A, et al. Should the new pneumococcal vaccine be used in high-risk children? Archives of Disease in Childhood 2002; 87: 18-21.
78. Finn A, et al. Conflicting advice. Archives of Disease in Childhood 2003; 88: 176.
79. Sheppard CL, et al. Diagnosis of invasive pneumococcal infection by PCR amplification of Streptococcus pneumoniae genomic fragments in blood: A multi-centre comparative study. Communicable Disease and Public Health 2003; 6: 221-227.
80. Cartwright K. Pneumococcal disease in Western Europe: Burden of disease, antibiotic resistance and management. European Journal of Pediatrics 2002; 161: 188-195.
81. Das P. Antibiotic resistance in Europe. Lancet Infectious Diseases 2003; 3: 398.
82. Karlowsky JA, et al. Factors associated with relative rates of antimicrobial resistance among Streptococcus pneumoniae in the United States: Results from the TRUST surveillance program (1998-2002). Clinical Infectious Diseases 2003; 36: 963-970.
83. Schmitt H-J, et al. Child vaccination policies in Europe: A report from the Summits of Independent European Vaccination Experts. Lancet Infectious Diseases 2003; 3: 103-108.